---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-258692"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:20:33.093591+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Corbus reports preliminary Q3 cash position of $104M as of Sep 30, 2025

## Summary
- Expected cash, cash equivalents, and investments of approximately $104.0 million.
- Includes $27.0 million in cash and cash equivalents.
- Figures are preliminary, subject to final closing procedures.
- No update on sales under Jefferies ATM agreement after September 30.

## SEC filing metadata
- accession: 0001193125-25-258692
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/0001193125-25-258692-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000119312525258692/crbp-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-258692
- JSON: https://secwatch.observer/filing/0001193125-25-258692.json
- Plain text: https://secwatch.observer/filing/0001193125-25-258692.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.